Stock Price
50.00
Daily Change
0.56 1.13%
Monthly
4.25%
Yearly
-2.63%
Q2 Forecast
48.44

Recordati reported EUR171.38M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
GlaxoSmithKline GBP 2.68B 518M Dec/2025
Hikma Pharmaceutical USD 288M 149M Dec/2025
Orion EUR 110.7M 26.1M Dec/2025
Sanofi EUR 2.75B 455M Dec/2025